<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04468191</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY20060082</org_study_id>
    <nct_id>NCT04468191</nct_id>
  </id_info>
  <brief_title>Fatigue in Patients With Amyotrophic Lateral Sclerosis</brief_title>
  <official_title>Quantifying Fatigue of the Respiratory and Swallowing Musculature in Patients With Amyotrophic Lateral Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Expiratory muscle strength training (EMST) is an emerging palliative intervention for
      prolonging pulmonary and swallow function in patients with amyotrophic lateral sclerosis
      (PALS), but it is unknown whether EMST may result in detrimental immediate to short-term
      fatigue because there is no way to measure fatigue non-invasively. This study will determine
      the immediate to short-term impact of EMST on objective respiratory and swallow function,
      whether subjective ratings of dyspnea and fatigue map to objective decompensation of
      respiratory and swallow function, and the ability to monitor fatigue of the respiratory and
      swallowing musculature non-invasively. Findings from this research study will provide
      preliminary evidence regarding optimal timing for PALS to complete EMST and will provide PALS
      and clinicians increased capabilities to monitor fatigue non-invasively.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This research proposal will determine the immediate impact of expiratory muscle strength
      training (EMST) on fatigue of the respiratory and swallowing musculature, whether objective
      decompensation translates to subjective dyspnea and fatigue, and whether high resolution
      cervical auscultation (HRCA) signal features can noninvasively capture and characterize
      physiologic decompensation that relates to fatigue in patients with amyotrophic lateral
      sclerosis (PALS) via three Specific Aims.

      Aim 1) Determine the impact of one EMST session on objective respiratory and swallow
      function.

      Hypothesis 1) One EMST session will result in reduced pulmonary function tests (PFTs)
      (maximum expiratory pressure, forced vital capacity, peak cough flow) and declines in swallow
      function (Videofluoroscopy (VF), HRCA). PALS will have greater reductions in PFTs, and
      objective declines in swallow function after the experimental condition compared to the
      control condition.

      Aim 2) Determine if objective decompensation translates to subjective ratings of dyspnea and
      fatigue after one EMST session.

      Hypothesis 2) Subjective ratings of dyspnea and fatigue (Situational Fatigue Scale; Dyspnea
      ALS-15) will be associated with objective decompensation in respiratory and swallow function
      (PFTs, VF, HRCA) after one EMST session.

      Aim 3) Investigate whether HRCA signal features analyses can non-invasively characterize
      immediate post-exercise physiologic changes in swallowing function that are related to
      fatigue.

      Hypothesis 3) Pre- to post-EMST changes in HRCA signal features will be associated with
      physiologic changes in swallowing as measured by VF analyses.

      This study will be a prospective study with randomized experimental and control conditions;
      and is directly related to the NIH funded research studies currently conducted in the
      Computational Deglutition (CD) Lab under the leadership of Dr. James Coyle and Dr. Ervin
      Sejdic.

      Participants: 20 PALS will be recruited to undergo VF before and after undergoing the
      randomly ordered experimental and control conditions on two separate nonconsecutive days
      within a two-week time frame.

      Baseline Procedures:

      PALS will be instructed not to eat a meal or engage in exercise within two hours of their
      visit. Following consent, baseline assessment procedures be obtained. All baseline
      measurements of swallowing and pulmonary function will be performed before any potentially
      fatigue-inducing procedures are performed (i.e. exercise training).

        1. The ALS functional rating scale revised (ALSFRS-R) (an instrument used to assess changes
           in functional status over time in PALS), will be completed.

        2. Prior to completing swallowing and pulmonary measurements, PALS will complete the
           situational fatigue scale (SFS), which measures fatigue that results from completing
           functional daily activities.

        3. Before undergoing swallowing and pulmonary measurements, PALS will also complete the
           Dyspnea ALS-15 (DALS-15), which is a measure of dyspnea that is known to be related to
           fatigue in PALS.

        4. PALS will undergo an assessment of swallow function with concurrent recordings of
           videofluoroscopy (VF) and high-resolution cervical auscultation (HRCA) signals prior to
           undergoing PFTs to mitigate fatigue from the PFTs as a confound. VF procedures will be
           conducted first, because ten swallows of thin liquid are unlikely to cause fatigue of
           the respiratory and swallow musculature that would impact PFTs.

        5. PALS will be seated upright in a chair and viewed in the lateral plane. HRCA signals
           will be simultaneously recorded from neck sensors (a contact microphone and
           accelerometer) that are attached to the anterior laryngeal framework with tape. VF and
           HRCA signals will be recorded onto a Labview Workstation. During each stage (pre-, post
           EMST) of VF, PALS will swallow ten thin liquid boluses of barium. Five liquid swallows
           will be a self-selected comfortable sip from a cup and five will be 3mL by spoon
           administered with a command to swallow. Presentation order for the liquid swallows will
           be randomized using a random number generator. If more than one aspiration event is
           observed during VF, the exam will be terminated immediately in order to ensure patient
           safety.

        6. PFTs following VF will include maximum expiratory pressure (MEP) (measured with the
           MicroRPM handheld MEP device (Micro Direct Inc., Lewiston, ME)), peak cough flow (PCF)
           (measured with a handheld peak flow meter (BV Medical, Barrington, IL)), and FVC
           (measured with the Spirodoc spirometer and WinspiroPRO computer software (Medical
           International Research, New Berlin, WI)). All PFTs will be completed three times with
           PALS sitting in an upright seated position with a nose clip in line with standard PFT
           protocols. The highest of three measurements will be used for analyses.

      EMST Training: PALS will use the EMST-150 device (Aspire Products, Gainesville, Florida) or
      the Philips Threshold PEP trainer (Philips Respironics, Cedar Grove, New Jersey). During the
      experimental condition, EMST devices will be set to 50% of PALS' highest MEP from their
      baseline PFT assessment. During the control condition, no resistance will be added, and the
      loaded spring will be removed from the device. For both experimental conditions, PALS will
      undergo the following standard treatment protocol:

        1. PALS will complete five sets of five repetitions using an EMST device.

        2. For each repetition, PALS will be instructed to take a deep breath in and blow until the
           valve releases.

        3. Between repetitions, PALs will have 10-15 seconds of rest before the next repetition.

        4. After each set, PALS will rest for one minute before completing the next set.

      Post-treatment procedures: Following the EMST session with either the device set to 50% load
      or the sham device, PALS will undergo the same procedures (VF, HRCA, PFTs) as described above
      in steps 1-6 of the baseline procedures
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2020</start_date>
  <completion_date type="Anticipated">March 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>This study will be a prospective study with randomized experimental and control conditions. Patients with ALS will undergo the experimental and control conditions in random order on two separate days within a two-week time frame.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>During the experimental condition, expiratory muscle strength training (EMST) devices will be set to 50% of patients with ALS' highest maximum expiratory pressure from their baseline pulmonary function test assessment. During the control condition, no resistance will be added, and the loaded spring will be removed from the device. For both experimental conditions, patients with ALS will be blinded to condition.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in forced vital capacity (FVC) between pre and post expiratory muscle strength training (EMST) experimental session</measure>
    <time_frame>pre and post EMST experimental session, up to 2 weeks</time_frame>
    <description>FVC is a measure of the total amount of air that can be breathed out during a pulmonary function test to measure lung function.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in forced vital capacity (FVC) between pre and post expiratory muscle strength training (EMST) sham session</measure>
    <time_frame>pre and post EMST sham session, up to 2 weeks</time_frame>
    <description>FVC is a measure of the total amount of air that can be breathed out during a pulmonary function test to measure lung function.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in peak cough flow (PCF) between pre and post expiratory muscle strength training (EMST) experimental session</measure>
    <time_frame>pre and post EMST experimental session, up to 2 weeks</time_frame>
    <description>PCF is a measure of air flow during a cough.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in peak cough flow (PCF) between pre and post expiratory muscle strength training (EMST) sham session</measure>
    <time_frame>pre and post EMST sham session, up to 2 weeks</time_frame>
    <description>PCF is a measure of air flow during a cough.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in maximum expiratory pressure (MEP) between pre and post expiratory muscle strength training (EMST) experimental session</measure>
    <time_frame>pre and post EMST experimental session, up to 2 weeks</time_frame>
    <description>Maximum expiratory pressure is a measure of strength of the respiratory muscles when breathing out</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in maximum expiratory pressure (MEP) between pre and post expiratory muscle strength training (EMST) sham session</measure>
    <time_frame>pre and post EMST sham session, up to 2 weeks</time_frame>
    <description>Maximum expiratory pressure is a measure of strength of the respiratory muscles when breathing out</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in temporal kinematic measures of swallowing between pre and post expiratory muscle strength training (EMST) experimental session</measure>
    <time_frame>pre and post EMST experimental session, up to 2 weeks</time_frame>
    <description>Timing measures of physiological events that occur during swallowing based on videofluoroscopic swallow studies (measured in frames per second)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in temporal kinematic measures of swallowing between pre and post expiratory muscle strength training (EMST) sham session</measure>
    <time_frame>pre and post EMST sham session, up to 2 weeks</time_frame>
    <description>Timing measures of physiological events that occur during swallowing based on videofluoroscopic swallow studies (measured in frames per second)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in spatial kinematic measures of swallowing between pre and post expiratory muscle strength training (EMST) experimental session</measure>
    <time_frame>pre and post EMST experimental session, up to 2 weeks</time_frame>
    <description>Distance measures of physiological events that occur during swallowing based on videofluoroscopic swallow studies (measured in pixels)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in spatial kinematic measures of swallowing between pre and post expiratory muscle strength training (EMST) sham session</measure>
    <time_frame>pre and post EMST sham session, up to 2 weeks</time_frame>
    <description>Distance measures of physiological events that occur during swallowing based on videofluoroscopic swallow studies (measured in pixels)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Modified Barium Swallow Impairment Profile (MBSImP) scores of swallowing between pre and post expiratory muscle strength training (EMST) experimental session</measure>
    <time_frame>pre and post EMST experimental session, up to 2 weeks</time_frame>
    <description>The MBSImP is a standardized clinical ordinal, categorical rating tool of 17 physiological components of swallowing</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Modified Barium Swallow Impairment Profile (MBSImP) scores of swallowing between pre and post expiratory muscle strength training (EMST) sham session</measure>
    <time_frame>pre and post EMST sham session, up to 2 weeks</time_frame>
    <description>The MBSImP is a standardized clinical ordinal, categorical rating tool of 17 physiological components of swallowing</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in high resolution cervical auscultation (HRCA) signal features between pre and post expiratory muscle strength training (EMST) experimental session</measure>
    <time_frame>pre and post EMST experimental session, up to 2 weeks</time_frame>
    <description>Feature extraction and analyses from HRCA will be completed before and after each EMST session and compared to VF to determine whether HRCA can detect fatigue related changes in swallow function.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in high resolution cervical auscultation (HRCA) signal features between pre and post expiratory muscle strength training (EMST) sham session</measure>
    <time_frame>pre and post EMST sham session, up to 2 weeks</time_frame>
    <description>Feature extraction and analyses from HRCA will be completed before and after each EMST session and compared to VF to determine whether HRCA can detect fatigue related changes in swallow function.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Amyotrophic Lateral Sclerosis</condition>
  <condition>Dysphagia</condition>
  <condition>Dyspnea</condition>
  <condition>Respiration Disorders</condition>
  <arm_group>
    <arm_group_label>Experimental, then sham</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with ALS in the experimental, then sham arm will undergo an expiratory muscle strength training (EMST) session with a device set to 50% of patients with ALS' highest maximum expiratory pressure from their baseline pulmonary function test assessment during their first study visit. Then, during their second study visit, patients with ALS will undergo an EMST session with a device set to 0% resistance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham, then experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with ALS in the sham, then experimental arm will undergo an expiratory muscle strength training (EMST) session with a device set to 0% resistance during their first study visit. Then, during their second study visit, patients with ALS will undergo an EMST session with a device set to 50% of patients with ALS' highest maximum expiratory pressure from their baseline pulmonary function test assessment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Experimental expiratory muscle strength training (EMST)</intervention_name>
    <description>The experimental EMST will involve blowing into a device with a spring-loaded valve set to 50% of the patient with ALS' maximum expiratory pressure.</description>
    <arm_group_label>Experimental, then sham</arm_group_label>
    <arm_group_label>Sham, then experimental</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham expiratory muscle strength training (EMST)</intervention_name>
    <description>The sham EMST will involve blowing into a device without a spring-loaded valve (0% resistance).</description>
    <arm_group_label>Experimental, then sham</arm_group_label>
    <arm_group_label>Sham, then experimental</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of ALS defined as possible, probable, or definite by a neurologist using the
             El Escorial criteria

          -  FVC&gt;65% predicted

          -  adequate cognition as defined by a score of &gt;10 on the ALS Cognitive Behavioral Screen

          -  adequate labial seal for completing pulmonary function tests and expiratory muscle
             strength training (EMST)

          -  on a regular/thin liquid diet

          -  no allergies to barium

          -  not oxygen-dependent

          -  no tracheostomy/ mechanical ventilation

          -  no history of other neurological or respiratory disorders

          -  no history of smoking

          -  no history of head and neck cancer or other major head/neck surgery or radiation
             therapy.

        Exclusion Criteria:

          -  FVC&lt;65% predicted

          -  inadequate cognition as defined by a score of &lt;10 on the ALS Cognitive Behavioral
             Screen -inadequate labial seal for completing pulmonary function tests and expiratory
             muscle strength training (EMST)

          -  not on a regular/thin liquid diet

          -  allergies to barium

          -  oxygen-dependent

          -  presence of tracheostomy/dependent on mechanical ventilation

          -  history of other neurological or respiratory disorders

          -  history of smoking

          -  history of head and neck cancer or other major head/neck surgery or radiation therapy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cara A Donohue, MA CCC-SLP</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James L Coyle, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cara A Donohue, MA CCC-SLP</last_name>
    <phone>724-307-8309</phone>
    <email>cad191@pitt.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>James L Coyle, PhD</last_name>
    <phone>412-383-6608</phone>
    <email>jcoyle@pitt.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center Presbyterian Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15260</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Cara A Donohue, MA CCC-SLP</last_name>
      <phone>724-307-8309</phone>
      <email>cad191@pitt.edu</email>
    </contact>
    <contact_backup>
      <last_name>James L Coyle, PhD</last_name>
      <phone>412-383-6608</phone>
      <email>jcoyle@pitt.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Ball LJ, Willis A, Beukelman DR, Pattee GL. A protocol for identification of early bulbar signs in amyotrophic lateral sclerosis. J Neurol Sci. 2001 Oct 15;191(1-2):43-53.</citation>
    <PMID>11676991</PMID>
  </reference>
  <reference>
    <citation>Kühnlein P, Gdynia HJ, Sperfeld AD, Lindner-Pfleghar B, Ludolph AC, Prosiegel M, Riecker A. Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis. Nat Clin Pract Neurol. 2008 Jul;4(7):366-74. doi: 10.1038/ncpneuro0853. Epub 2008 Jun 17. Review.</citation>
    <PMID>18560390</PMID>
  </reference>
  <reference>
    <citation>da Costa Franceschini A, Mourão LF. Dysarthria and dysphagia in Amyotrophic Lateral Sclerosis with spinal onset: a study of quality of life related to swallowing. NeuroRehabilitation. 2015;36(1):127-34. doi: 10.3233/NRE-141200.</citation>
    <PMID>25547774</PMID>
  </reference>
  <reference>
    <citation>Paris G, Martinaud O, Petit A, Cuvelier A, Hannequin D, Roppeneck P, Verin E. Oropharyngeal dysphagia in amyotrophic lateral sclerosis alters quality of life. J Oral Rehabil. 2013 Mar;40(3):199-204. doi: 10.1111/joor.12019. Epub 2012 Dec 27.</citation>
    <PMID>23278936</PMID>
  </reference>
  <reference>
    <citation>Andrews JA, Meng L, Kulke SF, Rudnicki SA, Wolff AA, Bozik ME, Malik FI, Shefner JM. Association Between Decline in Slow Vital Capacity and Respiratory Insufficiency, Use of Assisted Ventilation, Tracheostomy, or Death in Patients With Amyotrophic Lateral Sclerosis. JAMA Neurol. 2018 Jan 1;75(1):58-64. doi: 10.1001/jamaneurol.2017.3339.</citation>
    <PMID>29181534</PMID>
  </reference>
  <reference>
    <citation>Plowman EK, Watts SA, Tabor L, Robison R, Gaziano J, Domer AS, Richter J, Vu T, Gooch C. Impact of expiratory strength training in amyotrophic lateral sclerosis. Muscle Nerve. 2016 Jun;54(1):48-53. doi: 10.1002/mus.24990. Epub 2016 Mar 3.</citation>
    <PMID>26599236</PMID>
  </reference>
  <reference>
    <citation>Tabor LC, Rosado KM, Robison R, Hegland K, Humbert IA, Plowman EK. Respiratory training in an individual with amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2016 Sep 1;3(10):819-823. eCollection 2016 Oct.</citation>
    <PMID>27752517</PMID>
  </reference>
  <reference>
    <citation>Robison R, Tabor-Gray LC, Wymer JP, Plowman EK. Combined respiratory training in an individual with C9orf72 amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2018 Aug 21;5(9):1134-1138. doi: 10.1002/acn3.623. eCollection 2018 Sep.</citation>
    <PMID>30250869</PMID>
  </reference>
  <reference>
    <citation>Plowman EK, Tabor-Gray L, Rosado KM, Vasilopoulos T, Robison R, Chapin JL, Gaziano J, Vu T, Gooch C. Impact of expiratory strength training in amyotrophic lateral sclerosis: Results of a randomized, sham-controlled trial. Muscle Nerve. 2019 Jan;59(1):40-46. doi: 10.1002/mus.26292. Epub 2018 Nov 29.</citation>
    <PMID>29981250</PMID>
  </reference>
  <reference>
    <citation>de Almeida JP, Silvestre R, Pinto AC, de Carvalho M. Exercise and amyotrophic lateral sclerosis. Neurol Sci. 2012 Feb;33(1):9-15. doi: 10.1007/s10072-011-0921-9. Epub 2012 Jan 7. Review.</citation>
    <PMID>22228269</PMID>
  </reference>
  <reference>
    <citation>Harkawik, R., Coyle, J.L. Exercise for better ALS management? ASHA Leader. 2012; 17(11). http://leader.pubs.asha.org/article.aspx?articleid=2292004</citation>
  </reference>
  <reference>
    <citation>Casaburi R. Principles of exercise training. Chest. 1992 May;101(5 Suppl):263S-267S. Review.</citation>
    <PMID>1576847</PMID>
  </reference>
  <reference>
    <citation>Gibbons C, Pagnini F, Friede T, Young CA. Treatment of fatigue in amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2018 Jan 2;1:CD011005. doi: 10.1002/14651858.CD011005.pub2. Review.</citation>
    <PMID>29293261</PMID>
  </reference>
  <reference>
    <citation>Dudik JM, Coyle JL, Sejdić E. Dysphagia Screening: Contributions of Cervical Auscultation Signals and Modern Signal-Processing Techniques. IEEE Trans Hum Mach Syst. 2015 Aug;45(4):465-477.</citation>
    <PMID>26213659</PMID>
  </reference>
  <reference>
    <citation>Jestrović I, Dudik JM, Luan B, Coyle JL, Sejdić E. The effects of increased fluid viscosity on swallowing sounds in healthy adults. Biomed Eng Online. 2013 Sep 10;12:90. doi: 10.1186/1475-925X-12-90.</citation>
    <PMID>24020398</PMID>
  </reference>
  <reference>
    <citation>Dudik JM, Kurosu A, Coyle JL, Sejdić E. A statistical analysis of cervical auscultation signals from adults with unsafe airway protection. J Neuroeng Rehabil. 2016 Jan 22;13:7. doi: 10.1186/s12984-015-0110-9.</citation>
    <PMID>26801236</PMID>
  </reference>
  <reference>
    <citation>Dudik JM, Jestrović I, Luan B, Coyle JL, Sejdić E. Characteristics of Dry Chin-Tuck Swallowing Vibrations and Sounds. IEEE Trans Biomed Eng. 2015 Oct;62(10):2456-64. doi: 10.1109/TBME.2015.2431999. Epub 2015 May 12.</citation>
    <PMID>25974926</PMID>
  </reference>
  <reference>
    <citation>Prabhu DNF, Reddy NP, Canilang EP. Neural networks for recognition of acceleration pattern during swallowing and coughing. Proceedings of 16th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.1994; 1105-1106.</citation>
  </reference>
  <reference>
    <citation>Lee J, Steele CM, Chau T. Classification of healthy and abnormal swallows based on accelerometry and nasal airflow signals. Artif Intell Med. 2011 May;52(1):17-25. doi: 10.1016/j.artmed.2011.03.002. Epub 2011 May 6.</citation>
    <PMID>21549579</PMID>
  </reference>
  <reference>
    <citation>Sejdić E, Dudik JM, Kurosu A, Jestrović I, Coyle JL. Understanding differences between healthy swallows and penetration-aspiration swallows via compressive sensing of tri-axial swallowing accelerometry signals. Proc SPIE Int Soc Opt Eng. 2014 May 23;9190:91090M.</citation>
    <PMID>25332758</PMID>
  </reference>
  <reference>
    <citation>Dudik JM, Coyle JL, El-Jaroudi A, Mao ZH, Sun M, Sejdić E. Deep Learning for Classification of Normal Swallows in Adults. Neurocomputing. 2018 Apr 12;285:1-9. doi: 10.1016/j.neucom.2017.12.059. Epub 2018 Jan 31.</citation>
    <PMID>29755210</PMID>
  </reference>
  <reference>
    <citation>He Q, Perera S, Khalifa Y, Zhang Z, Mahoney AS, Sabry A, Donohue C, Coyle JL, Sejdic E. The Association of High Resolution Cervical Auscultation Signal Features With Hyoid Bone Displacement During Swallowing. IEEE Trans Neural Syst Rehabil Eng. 2019 Sep;27(9):1810-1816. doi: 10.1109/TNSRE.2019.2935302. Epub 2019 Aug 21.</citation>
    <PMID>31443032</PMID>
  </reference>
  <reference>
    <citation>Zhang Z, Perera S, Donohue C, Kurosu A, Mahoney AS, Coyle JL, Sejdić E. The Prediction of Risk of Penetration-Aspiration Via Hyoid Bone Displacement Features. Dysphagia. 2020 Feb;35(1):66-72. doi: 10.1007/s00455-019-10000-5. Epub 2019 Mar 27.</citation>
    <PMID>30919104</PMID>
  </reference>
  <reference>
    <citation>Mao S, Zhang Z, Khalifa Y, Donohue C, Coyle JL, Sejdic E. Neck sensor-supported hyoid bone movement tracking during swallowing. R Soc Open Sci. 2019 Jul 10;6(7):181982. doi: 10.1098/rsos.181982. eCollection 2019 Jul.</citation>
    <PMID>31417694</PMID>
  </reference>
  <reference>
    <citation>Donohue C, Mao S, Sejdić E, Coyle JL. Tracking Hyoid Bone Displacement During Swallowing Without Videofluoroscopy Using Machine Learning of Vibratory Signals. Dysphagia. 2020 May 17. doi: 10.1007/s00455-020-10124-z. [Epub ahead of print]</citation>
    <PMID>32419103</PMID>
  </reference>
  <reference>
    <citation>Khalifa Y, Donohue C, Coyle JL, Sejdic E. High resolution cervical auscultation-guided detection of the duration of upper esophageal sphincter opening. IEEE Journal of Biomedical and Health Informatics. 2020.</citation>
  </reference>
  <reference>
    <citation>Sabry A, Shitong M, Mahoney A, Khalifa Y, Sejdic E, Coyle J. Automatic estimation of laryngeal vestibular closure duration using high resolution cervical auscultation signals. Presentation at the American Speech-Language Hearing Association Convention, Orlando, FL. 2019.</citation>
  </reference>
  <reference>
    <citation>Donohue C, Zhenwei Z, Mahoney A, Perera S, Sejdic E, Coyle J. Do machine ratings of hyoid bone displacement during videofluoroscopy match clinician ratings using the MBSImP? Presentation at the American Speech-Language Hearing Association Annual Meeting, Boston, MA. November 2018.</citation>
  </reference>
  <reference>
    <citation>Sabry A, Mahoney A, Perera S, Sejdic E, Coyle J. Are HRCA signal features associated with clinical ratings of pharyngeal residue using the MBSImP? Presentation at the Dysphagia Research Society Annual Meeting, San Diego, CA. March 2019.</citation>
  </reference>
  <reference>
    <citation>Donohue C, Khalifa Y, Sejdic E, Coyle J. How closely do machine ratings of duration of UES during videofluoroscopy approximate clinician ratings using the MBSImP? Abstract accepted for presentation at the Dysphagia Research Society annual meeting, San Diego, CA, USA. 2018.</citation>
  </reference>
  <reference>
    <citation>Kurosu A, Coyle JL, Dudik JM, Sejdic E. Detection of Swallow Kinematic Events From Acoustic High-Resolution Cervical Auscultation Signals in Patients With Stroke. Arch Phys Med Rehabil. 2019 Mar;100(3):501-508. doi: 10.1016/j.apmr.2018.05.038. Epub 2018 Jul 30.</citation>
    <PMID>30071198</PMID>
  </reference>
  <reference>
    <citation>Donohue C, Khalifa Y, Perera S, Sejdic E, Coyle JL. Can HRCA signals differentiate between swallows from healthy people and swallows from people with neurodegenerative diseases? Dysphagia. Under review.</citation>
  </reference>
  <reference>
    <citation>Hiramatsu T, Kataoka H, Osaki M, Hagino H. Effect of aging on oral and swallowing function after meal consumption. Clin Interv Aging. 2015 Jan 9;10:229-35. doi: 10.2147/CIA.S75211. eCollection 2015.</citation>
    <PMID>25624755</PMID>
  </reference>
  <reference>
    <citation>Kays SA, Hind JA, Gangnon RE, Robbins J. Effects of dining on tongue endurance and swallowing-related outcomes. J Speech Lang Hear Res. 2010 Aug;53(4):898-907. doi: 10.1044/1092-4388(2009/09-0048).</citation>
    <PMID>20689047</PMID>
  </reference>
  <reference>
    <citation>Kim DG, Hong YH, Shin JY, Lee KW, Park KS, Seong SY, Sung JJ. Pattern of Respiratory Deterioration in Sporadic Amyotrophic Lateral Sclerosis According to Onset Lesion by Using Respiratory Function Tests. Exp Neurobiol. 2015 Dec;24(4):351-7. doi: 10.5607/en.2015.24.4.351. Epub 2015 Nov 4.</citation>
    <PMID>26713082</PMID>
  </reference>
  <reference>
    <citation>Schmidt EP, Drachman DB, Wiener CM, Clawson L, Kimball R, Lechtzin N. Pulmonary predictors of survival in amyotrophic lateral sclerosis: use in clinical trial design. Muscle Nerve. 2006 Jan;33(1):127-32.</citation>
    <PMID>16258948</PMID>
  </reference>
  <reference>
    <citation>Suárez AA, Pessolano FA, Monteiro SG, Ferreyra G, Capria ME, Mesa L, Dubrovsky A, De Vito EL. Peak flow and peak cough flow in the evaluation of expiratory muscle weakness and bulbar impairment in patients with neuromuscular disease. Am J Phys Med Rehabil. 2002 Jul;81(7):506-11.</citation>
    <PMID>12131177</PMID>
  </reference>
  <reference>
    <citation>Baumann F, Henderson RD, Morrison SC, Brown M, Hutchinson N, Douglas JA, Robinson PJ, McCombe PA. Use of respiratory function tests to predict survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11(1-2):194-202. doi: 10.3109/17482960902991773.</citation>
    <PMID>19452343</PMID>
  </reference>
  <reference>
    <citation>Vogt S, Petri S, Dengler R, Heinze HJ, Vielhaber S. Dyspnea in Amyotrophic Lateral Sclerosis: Rasch-Based Development and Validation of a Patient-Reported Outcome (DALS-15). J Pain Symptom Manage. 2018 Nov;56(5):736-745.e2. doi: 10.1016/j.jpainsymman.2018.08.009. Epub 2018 Aug 24.</citation>
    <PMID>30145215</PMID>
  </reference>
  <reference>
    <citation>Homepage - ALS Association. ALSA.org. http://www.alsa.org/. Accessed April 10, 2019.</citation>
  </reference>
  <reference>
    <citation>Wilkins T, Gillies RA, Thomas AM, Wagner PJ. The prevalence of dysphagia in primary care patients: a HamesNet Research Network study. J Am Board Fam Med. 2007 Mar-Apr;20(2):144-50.</citation>
    <PMID>17341750</PMID>
  </reference>
  <reference>
    <citation>Barer DH. The natural history and functional consequences of dysphagia after hemispheric stroke. J Neurol Neurosurg Psychiatry. 1989 Feb;52(2):236-41.</citation>
    <PMID>2564884</PMID>
  </reference>
  <reference>
    <citation>Flowers HL, Silver FL, Fang J, Rochon E, Martino R. The incidence, co-occurrence, and predictors of dysphagia, dysarthria, and aphasia after first-ever acute ischemic stroke. J Commun Disord. 2013 May-Jun;46(3):238-48. doi: 10.1016/j.jcomdis.2013.04.001. Epub 2013 Apr 12.</citation>
    <PMID>23642855</PMID>
  </reference>
  <reference>
    <citation>Gordon C, Hewer RL, Wade DT. Dysphagia in acute stroke. Br Med J (Clin Res Ed). 1987 Aug 15;295(6595):411-4.</citation>
    <PMID>3115478</PMID>
  </reference>
  <reference>
    <citation>Alagiakrishnan K, Bhanji RA, Kurian M. Evaluation and management of oropharyngeal dysphagia in different types of dementia: a systematic review. Arch Gerontol Geriatr. 2013 Jan-Feb;56(1):1-9. doi: 10.1016/j.archger.2012.04.011. Epub 2012 May 19. Review.</citation>
    <PMID>22608838</PMID>
  </reference>
  <reference>
    <citation>García-Peris P, Parón L, Velasco C, de la Cuerda C, Camblor M, Bretón I, Herencia H, Verdaguer J, Navarro C, Clave P. Long-term prevalence of oropharyngeal dysphagia in head and neck cancer patients: Impact on quality of life. Clin Nutr. 2007 Dec;26(6):710-7. Epub 2007 Oct 22.</citation>
    <PMID>17954003</PMID>
  </reference>
  <reference>
    <citation>Skoretz SA, Flowers HL, Martino R. The incidence of dysphagia following endotracheal intubation: a systematic review. Chest. 2010 Mar;137(3):665-73. doi: 10.1378/chest.09-1823. Review.</citation>
    <PMID>20202948</PMID>
  </reference>
  <reference>
    <citation>Martin-Harris B. Clinical implications of respiratory-swallowing interactions. Curr Opin Otolaryngol Head Neck Surg. 2008 Jun;16(3):194-9. doi: 10.1097/MOO.0b013e3282febd4b. Review.</citation>
    <PMID>18475070</PMID>
  </reference>
  <reference>
    <citation>Larkindale J, Yang W, Hogan PF, Simon CJ, Zhang Y, Jain A, Habeeb-Louks EM, Kennedy A, Cwik VA. Cost of illness for neuromuscular diseases in the United States. Muscle Nerve. 2014 Mar;49(3):431-8. doi: 10.1002/mus.23942. Epub 2014 Jan 28.</citation>
    <PMID>23836444</PMID>
  </reference>
  <reference>
    <citation>Lechtzin N, Wiener CM, Clawson L, Chaudhry V, Diette GB. Hospitalization in amyotrophic lateral sclerosis: causes, costs, and outcomes. Neurology. 2001 Mar 27;56(6):753-7.</citation>
    <PMID>11274310</PMID>
  </reference>
  <reference>
    <citation>Enoka RM, Duchateau J. Muscle fatigue: what, why and how it influences muscle function. J Physiol. 2008 Jan 1;586(1):11-23. Epub 2007 Aug 16. Review.</citation>
    <PMID>17702815</PMID>
  </reference>
  <reference>
    <citation>Hunter SK, Duchateau J, Enoka RM. Muscle fatigue and the mechanisms of task failure. Exerc Sport Sci Rev. 2004 Apr;32(2):44-9. Review.</citation>
    <PMID>15064647</PMID>
  </reference>
  <reference>
    <citation>Kirkinezos IG, Hernandez D, Bradley WG, Moraes CT. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis. Ann Neurol. 2003 Jun;53(6):804-7.</citation>
    <PMID>12783429</PMID>
  </reference>
  <reference>
    <citation>Mahoney DJ, Rodriguez C, Devries M, Yasuda N, Tarnopolsky MA. Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis. Muscle Nerve. 2004 May;29(5):656-62.</citation>
    <PMID>15116368</PMID>
  </reference>
  <reference>
    <citation>Aitkens SG, McCrory MA, Kilmer DD, Bernauer EM. Moderate resistance exercise program: its effect in slowly progressive neuromuscular disease. Arch Phys Med Rehabil. 1993 Jul;74(7):711-5.</citation>
    <PMID>8328892</PMID>
  </reference>
  <reference>
    <citation>Dal Bello-Haas V, Florence JM. Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database Syst Rev. 2013 May 31;(5):CD005229. doi: 10.1002/14651858.CD005229.pub3. Review.</citation>
    <PMID>23728653</PMID>
  </reference>
  <reference>
    <citation>Kent-Braun JA, Miller RG. Central fatigue during isometric exercise in amyotrophic lateral sclerosis. Muscle Nerve. 2000 Jun;23(6):909-14.</citation>
    <PMID>10842267</PMID>
  </reference>
  <reference>
    <citation>Vucic S, Cheah BC, Kiernan MC. Maladaptation of cortical circuits underlies fatigue and weakness in ALS. Amyotroph Lateral Scler. 2011 Nov;12(6):414-20. doi: 10.3109/17482968.2011.597403. Epub 2011 Aug 11.</citation>
    <PMID>21830989</PMID>
  </reference>
  <reference>
    <citation>Kent-Braun JA, Fitts RH, Christie A. Skeletal muscle fatigue. Compr Physiol. 2012 Apr;2(2):997-1044. doi: 10.1002/cphy.c110029. Review.</citation>
    <PMID>23798294</PMID>
  </reference>
  <reference>
    <citation>Tabor L, Gaziano J, Watts S, Robison R, Plowman EK. Defining Swallowing-Related Quality of Life Profiles in Individuals with Amyotrophic Lateral Sclerosis. Dysphagia. 2016 Jun;31(3):376-82. doi: 10.1007/s00455-015-9686-2. Epub 2016 Feb 2.</citation>
    <PMID>26837611</PMID>
  </reference>
  <reference>
    <citation>Luchesi KF, Campos BM, Mituuti CT. Identification of swallowing disorders: the perception of patients with neurodegenerative diseases. Codas. 2018 Nov 29;30(6):e20180027. doi: 10.1590/2317-1782/20182018027. Portuguese, English.</citation>
    <PMID>30517269</PMID>
  </reference>
  <reference>
    <citation>Roth E J, Berkowitz M, Nussbaum SB, Oken JE, Powley SG, White KC. Course 510: Spinal cord injury: Expiratory Muscle Training in Spinal Cord Injury: A Randomized Controlled Clinical Trial. Archives of Physical Medicine and Rehabilitation. 2008; 89(11). doi:10.1016/j.apmr.2008.09.019</citation>
  </reference>
  <reference>
    <citation>Troche MS, Okun MS, Rosenbek JC, Musson N, Fernandez HH, Rodriguez R, Romrell J, Pitts T, Wheeler-Hegland KM, Sapienza CM. Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: a randomized trial. Neurology. 2010 Nov 23;75(21):1912-9. doi: 10.1212/WNL.0b013e3181fef115.</citation>
    <PMID>21098406</PMID>
  </reference>
  <reference>
    <citation>Neves LF, Reis MH, Plentz RD, Matte DL, Coronel CC, Sbruzzi G. Expiratory and expiratory plus inspiratory muscle training improves respiratory muscle strength in subjects with COPD: systematic review. Respir Care. 2014 Sep;59(9):1381-8. doi: 10.4187/respcare.02793. Epub 2014 Apr 29. Review.</citation>
    <PMID>24782553</PMID>
  </reference>
  <reference>
    <citation>Patchett KK, Hausenblas HA, Christine M. Expiratory Muscle Strength Training for Dysphagia in Chronic Obstructive Pulmonary Disease: A Meta-analysis and Systematic Review. 2017;(August 2015).</citation>
  </reference>
  <reference>
    <citation>Ferreira GD, Costa AC, Plentz RD, Coronel CC, Sbruzzi G. Respiratory training improved ventilatory function and respiratory muscle strength in patients with multiple sclerosis and lateral amyotrophic sclerosis: systematic review and meta-analysis. Physiotherapy. 2016 Sep;102(3):221-8. doi: 10.1016/j.physio.2016.01.002. Epub 2016 Mar 26. Review.</citation>
    <PMID>27026167</PMID>
  </reference>
  <reference>
    <citation>Park JS, Oh DH, Chang MY, Kim KM. Effects of expiratory muscle strength training on oropharyngeal dysphagia in subacute stroke patients: a randomised controlled trial. J Oral Rehabil. 2016 May;43(5):364-72. doi: 10.1111/joor.12382. Epub 2016 Jan 24.</citation>
    <PMID>26803525</PMID>
  </reference>
  <reference>
    <citation>Hegland KW, Davenport PW, Brandimore AE, Singletary FF, Troche MS. Rehabilitation of Swallowing and Cough Functions Following Stroke: An Expiratory Muscle Strength Training Trial. Arch Phys Med Rehabil. 2016 Aug;97(8):1345-51. doi: 10.1016/j.apmr.2016.03.027. Epub 2016 Apr 26.</citation>
    <PMID>27130637</PMID>
  </reference>
  <reference>
    <citation>Hutcheson KA, Barrow MP, Plowman EK, Lai SY, Fuller CD, Barringer DA, Eapen G, Wang Y, Hubbard R, Jimenez SK, Little LG, Lewin JS. Expiratory muscle strength training for radiation-associated aspiration after head and neck cancer: A case series. Laryngoscope. 2018 May;128(5):1044-1051. doi: 10.1002/lary.26845. Epub 2017 Aug 22.</citation>
    <PMID>28833185</PMID>
  </reference>
  <reference>
    <citation>Pinto S, Swash M, de Carvalho M. Respiratory exercise in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2012 Jan;13(1):33-43. doi: 10.3109/17482968.2011.626052.</citation>
    <PMID>22214352</PMID>
  </reference>
  <reference>
    <citation>Malatra I. Respiratory Muscle Fatigue and the Effects on Swallowing. ProQuest. 2016.</citation>
  </reference>
  <reference>
    <citation>Steele CM, Cichero JA. Physiological factors related to aspiration risk: a systematic review. Dysphagia. 2014 Jun;29(3):295-304. doi: 10.1007/s00455-014-9516-y. Epub 2014 Feb 23. Review.</citation>
    <PMID>24562507</PMID>
  </reference>
  <reference>
    <citation>Donohue C, Coyle JL. Impact of respiratory interventions on pulmonary, cough, and swallowing in ALS. ASHA Perspectives. Under review.</citation>
  </reference>
  <reference>
    <citation>Carvalho DV, Santos RMS, Magalhães HC, Souza MS, Christo PP, Almeida-Leite CM, Scalzo PL. Can fatigue predict walking capacity of patients with Parkinson's disease? Arq Neuropsiquiatr. 2020 Feb;78(2):70-75. doi: 10.1590/0004-282X20190136.</citation>
    <PMID>32159720</PMID>
  </reference>
  <reference>
    <citation>Mänty M, de Leon CF, Rantanen T, Era P, Pedersen AN, Ekmann A, Schroll M, Avlund K. Mobility-related fatigue, walking speed, and muscle strength in older people. J Gerontol A Biol Sci Med Sci. 2012 May;67(5):523-9. doi: 10.1093/gerona/glr183. Epub 2011 Oct 19.</citation>
    <PMID>22016363</PMID>
  </reference>
  <reference>
    <citation>Dalgas U, Langeskov-Christensen M, Skjerbæk A, Jensen E, Baert I, Romberg A, Santoyo Medina C, Gebara B, Maertens de Noordhout B, Knuts K, Béthoux F, Rasova K, Severijns D, Bibby BM, Kalron A, Norman B, Van Geel F, Wens I, Feys P. Is the impact of fatigue related to walking capacity and perceived ability in persons with multiple sclerosis? A multicenter study. J Neurol Sci. 2018 Apr 15;387:179-186. doi: 10.1016/j.jns.2018.02.026. Epub 2018 Feb 16.</citation>
    <PMID>29571860</PMID>
  </reference>
  <reference>
    <citation>Vogt S, Schreiber S, Pfau G, Kollewe K, Heinze HJ, Dengler R, Petri S, Vielhaber S, Brinkers M. Dyspnea as a Fatigue-Promoting Factor in ALS and the Role of Objective Indicators of Respiratory Impairment. J Pain Symptom Manage. 2020 Mar 5. pii: S0885-3924(20)30124-X. doi: 10.1016/j.jpainsymman.2020.02.021. [Epub ahead of print]</citation>
    <PMID>32145336</PMID>
  </reference>
  <reference>
    <citation>Yang CM, Wu CH. The situational fatigue scale: a different approach to measuring fatigue. Qual Life Res. 2005 Jun;14(5):1357-62.</citation>
    <PMID>16047510</PMID>
  </reference>
  <reference>
    <citation>Moore VC. Spirometry: Step by step. Breathe, 2012; 8(3), 233-240. https://doi.org/10.1183/20734735.0021711</citation>
  </reference>
  <reference>
    <citation>Cheung HJ, Cheung L. Coaching patients during pulmonary function testing: A practical guide. Can J Respir Ther. 2015 Summer;51(3):65-8. Review.</citation>
    <PMID>26283871</PMID>
  </reference>
  <reference>
    <citation>Duncan P, Richards L, Wallace D, Stoker-Yates J, Pohl P, Luchies C, Ogle A, Studenski S. A randomized, controlled pilot study of a home-based exercise program for individuals with mild and moderate stroke. Stroke. 1998 Oct;29(10):2055-60.</citation>
    <PMID>9756581</PMID>
  </reference>
  <reference>
    <citation>VanSwearingen JM, Perera S, Brach JS, Cham R, Rosano C, Studenski SA. A randomized trial of two forms of therapeutic activity to improve walking: effect on the energy cost of walking. J Gerontol A Biol Sci Med Sci. 2009 Nov;64(11):1190-8. doi: 10.1093/gerona/glp098. Epub 2009 Jul 30.</citation>
    <PMID>19643842</PMID>
  </reference>
  <reference>
    <citation>Brach JS, Van Swearingen JM, Perera S, Wert DM, Studenski S. Motor learning versus standard walking exercise in older adults with subclinical gait dysfunction: a randomized clinical trial. J Am Geriatr Soc. 2013 Nov;61(11):1879-86. doi: 10.1111/jgs.12506. Epub 2013 Oct 28.</citation>
    <PMID>24219189</PMID>
  </reference>
  <reference>
    <citation>Weiner DK, Gentili A, Rossi M, Coffey-Vega K, Rodriguez KL, Hruska KL, Hausmann L, Perera S. Aging Back Clinics-a Geriatric Syndrome Approach to Treating Chronic Low Back Pain in Older Adults: Results of a Preliminary Randomized Controlled Trial. Pain Med. 2020 Feb 1;21(2):274-290. doi: 10.1093/pm/pnz179.</citation>
    <PMID>31503275</PMID>
  </reference>
  <reference>
    <citation>Resnick J, Gupta N, Wagner J, Costa G, Cruz RJ Jr, Martin L, Koritsky DA, Perera S, Matarese L, Eid K, Schuster B, Roberts M, Greenspan S, Abu-Elmagd K. Skeletal integrity and visceral transplantation. Am J Transplant. 2010 Oct;10(10):2331-40. doi: 10.1111/j.1600-6143.2010.03245.x. Epub 2010 Sep 3.</citation>
    <PMID>20825384</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>June 22, 2020</study_first_submitted>
  <study_first_submitted_qc>July 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 13, 2020</study_first_posted>
  <last_update_submitted>July 7, 2020</last_update_submitted>
  <last_update_submitted_qc>July 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Cara Donohue</investigator_full_name>
    <investigator_title>MA CCC-SLP/PhD Student</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyspnea</mesh_term>
    <mesh_term>Respiration Disorders</mesh_term>
    <mesh_term>Motor Neuron Disease</mesh_term>
    <mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Fatigue</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

